5. RTFCCR/LLS Patient-Focused Immunotherapy Research Grant for Blood Cancer
The RTFCCR/LLS Patient-Focused Immunotherapy Research Grant for Blood Cancer is a partnership of the LLS and the Swiss private foundation Rising Tide Foundation for Clinical Cancer Research (RTFCCR). It is focused on stimulating innovative and clinically relevant cancer research that has the highest potential for near-term patient impact in terms of clinical application, therapeutic outcomes and quality of life. The application process for RTFCCR/LLS Patient-Focused ImmunotherapyResearch Grant for Blood Cancer are closed, and the results of applications currently under review will be announced next October.
